Table 2. Metabolic profile of multi-low dose, streptozotocin/high-fat diet mice treated with XMetS and controls.
Non-diabetic+control IgG | Diabetic+control IgG | Diabetic+XMetS | |
Body Weight (g) | 42.5±3.1* | 35.5±3.2 | 38.4±2.3* |
Beta hydroxybutyrate (mmol/L) | 0.26±0.05* | 4.79±1.8 | 1.05±0.61* |
Glucose (mg/dL) | 113±19* | 488±40 | 183±20* |
Total cholesterol (mg/dL) | 154±17* | 175±29 | 159±31 |
Non-HDL cholesterol (mg/dL) | 34±10* | 101±32 | 63±21* |
Insulin (pg/mL) | 1006±332* | 336±301 | 137±51* |
C-peptide (pM) | 204±69* | 142±67 | 67±63* |
At the end of the 6-week study with multi-low dose, streptozotocin/high-fat diet mice, the animals were fasted 14 hours, weighed and plasma was obtained to determine the above parameters. Mice (n = 8/group) were treated with antibody at 10 mg/kg, twice weekly. Values are shown as mean ± SEM. *p<0.05 vs. diabetic+control IgG.